Article Details

Addex Therapeutics leads CHF 2 million investment in Stalicla

Retrieved on: 2025-07-14 17:17:13

Tags for this article:

Click the tags to see associated articles and topics

Addex Therapeutics leads CHF 2 million investment in Stalicla. View article details on hiswai:

Excerpt

A hub for neurotherapeutic innovation. The collaboration reflects growing synergies within Geneva's neuroscience innovation landscape. In April 2024, ...

Article found on: ggba.swiss

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo